BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/RECEPTOR-TYPE/Compounds

Compounds That Target RECEPTOR-TYPE

Receptor-type tyrosine-protein kinase FLT3 (human) · 3 compounds in BiohacksAI corpus

RECEPTOR-TYPE (Receptor-type tyrosine-protein kinase FLT3 (human)) is a biological target with 3 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into RECEPTOR-TYPE modulation for therapeutic and biohacking applications.

View RECEPTOR-TYPE target page →UniProt: P36888 ↗
Most Studied Compounds for RECEPTOR-TYPE
1
Sorafenib
300+
studies
2
Taxifolin
300+
studies
3
Sp600125
117+
studies
All 3 Compounds — Ranked by Evidence
1
Sorafenib
300+
studies
1.79
confidence
2
Sp600125
117+
studies
0.69
confidence
3
Taxifolin
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for RECEPTOR-TYPE (Receptor-type tyrosine-protein kinase FLT3 (human)). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: RECEPTOR-TYPE target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.